CompuGroup Medical SE & Co. KGaA · ISIN: DE000A288904 · EQS - Company News

CompuGroup Medical enters into an investment agreement with CVC Capital Partners

CompuGroup Medical enters into an investment agreement with CVC Capital Partners  CVC announces intention to launch a voluntary public tender offer to all free float shareholders   CVC to launch voluntary public tender offer for EUR 22.00 per share, subsequent delisting envisaged Significant premium of 51.1% to the 3M VWAP and 33.5% to closing price as of December 6, 2024 provides shareholders with opportunity to realize value immediately Founding family Gotthardt signs strategic partnership ...

XETR:COP Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News CompuGroup Medical SE & Co. KGaA

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (25)
Short Selling (DE) (2)
Short Selling (UK) (0)
09 December 2024 09:19AM
CompuGroup Medical enters into an investment agreement with CVC Capital Partners
DE000A288904
CompuGroup Medical enters into an investment agreement with CVC Capital Partners  CVC announces intention to launch a voluntary public tender offer to all free float shareholders   CVC to launch voluntary public tender offer for EUR 22.00 per share, subsequent delisting envisaged Significant premium of 51.1% to the 3M VWAP and 33.5% to closing pr...
CompuGroup Medical SE & Co. KGaA
About the publication
09 December 2024 09:08AM
CompuGroup Medical SE & Co. KGaA; Bidder: SCUR-Alpha 269 GmbH (in future: Caesar BidCo GmbH)
DE000A288904
EQS-WpÜG: SCUR-Alpha 269 GmbH (künftig: Caesar BidCo GmbH) / Tender Offer Tender Offer / Target company: CompuGroup Medical SE & Co. KGaA; Bidder: SCUR-Alpha 269 GmbH (in future: Caesar BidCo GmbH) 09.12.2024 / 09:08 CET/CEST Dissemination of an announcement according to the German Securities Acquisition and Takeover Act (WpÜG), trans...
SCUR-Alpha 269 GmbH (künftig: Caesar BidCo GmbH)
About the publication
09 December 2024 09:08AM
CVC announces a voluntary public tender offer based on an investment agreement concluded with CompuGroup Medical SE & Co. KGaA
DE000A288904
Today, CompuGroup Medical SE & Co. KGaA (CGM or the Company), together with its general partner, CompuGroup Medical Management SE, its majority shareholder GT 1 Vermögensverwaltung GmbH (the Majority Shareholder), Kronen 2944 GmbH (to be renamed GT2 Beteiligungen und Software GmbH, GT2) as well as SCUR-Alpha 269 GmbH (to be renamed Caesar BidCo...
CompuGroup Medical SE & Co. KGaA
About the publication
09 December 2024 09:08AM
CVC announces a voluntary public tender offer based on an investment agreement concluded with CompuGroup Medical SE & Co. KGaA
DE000A288904
Today, CompuGroup Medical SE & Co. KGaA (CGM or the Company), together with its general partner, CompuGroup Medical Management SE, its majority shareholder GT 1 Vermögensverwaltung GmbH (the Majority Shareholder), Kronen 2944 GmbH (to be renamed GT2 Beteiligungen und Software GmbH, GT2) as well as SCUR-Alpha 269 GmbH (to be renamed Caesar BidCo...
CompuGroup Medical SE & Co. KGaA
About the publication
08 December 2024 11:01PM
CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC
DE000A288904
CompuGroup Medical SE & Co. KGaA (Company) confirms that the Company and the shareholder group around the founding family Gotthardt are in advanced discussions with the private equity firm CVC Capital Partners plc (CVC) regarding a potential conclusion of an investment agreement for the submission of a voluntary public tender offer to the share...
CompuGroup Medical SE & Co. KGaA
About the publication
07 November 2024 07:35AM
CGM drives innovation in the third quarter while recording earnings decline with almost stable revenues
DE000A288904
CGM drives innovation in the third quarter while recording earnings decline with almost stable revenues Koblenz - CompuGroup Medical, one of the world's leading e-health providers, recorded revenues of EUR 283.4 million in the third quarter of the 2024 financial year, slightly (-1 percent) below the previous year's level (PY: EUR 285.7 million), w...
CompuGroup Medical SE & Co. KGaA
About the publication
31 July 2024 06:40PM
CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO
DE000A288904
CompuGroup Medical appoints Prof. Dr. Daniel Gotthardt as new CEO Koblenz. CompuGroup Medical announced today that the Administrative Board appoints the company founder’s son, Prof. (apl.) Dr. med. Daniel Gotthardt, as CEO of CGM effective as of September 1, 2024. The current CEO Michael Rauch will leave the company in the best mutual agreement to...
CompuGroup Medical SE & Co. KGaA
About the publication
31 July 2024 06:36PM
CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO
DE000A288904
CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO Koblenz, Germany. The general partner of CompuGroup Medical SE & Co. KGaA (the “Company”) (ISIN: DE000A288904 | WKN: A28890) announces that the Administrative Board of CompuGroup Medical Management SE and CEO Michael Rauch decided today in mutual agreement to ...
CompuGroup Medical SE & Co. KGaA
About the publication
31 July 2024 10:51AM
CompuGroup Medical wins digitization expert Ulf Hönick for the pharmacy business
DE000A288904
CompuGroup Medical wins digitization expert Ulf Hönick for the pharmacy business Koblenz - CompuGroup Medical SE & Co. KGaA (CGM), one of the world's leading e-health providers, has gained another experienced healthcare expert. On August 1, Ulf Hönick will take over the management of CGM Lauer. Over the past few years, Ulf Hönick has supporte...
CompuGroup Medical SE & Co. KGaA
About the publication
17 July 2024 10:07AM
100 million e-prescriptions issued in CGM's German practice software systems
DE000A288904
100 million e-prescriptions issued in CGM's German practice software systems Koblenz - 100 million e-prescriptions have been issued in the German ambulatory information systems supplied by CompuGroup Medical (CGM). CGM is thus the first practice software provider to exceed this mark. More than 32 percent of all e-prescriptions generated in German ...
CompuGroup Medical SE & Co. KGaA
About the publication
15 July 2024 07:28AM
CompuGroup Medical SE & Co. KGaA publishes half-year figures for the financial year 2024
DE000A288904
CompuGroup Medical SE & Co. KGaA publishes half-year figures for the financial year 2024 Against the backdrop of the ad-hoc announcement on July 9, 2024, the general partner of CompuGroup Medical SE & Co. KGaA (ISIN: DE000A288904 | WKN: A28890) (“CGM”) has decided to prepone the publication of the financial results for the first half of th...
CompuGroup Medical SE & Co. KGaA
About the publication
09 July 2024 04:11PM
CompuGroup Medical SE & Co. KGaA expects lower revenues and therefore revises its financial year 2024 guidance
DE000A288904
At CompuGroup Medical SE & Co. KGaA (“CGM”), the preliminary consolidation of revenues for the second quarter and an updated full year forecast result in lower expected revenues than originally anticipated for the financial year 2024. The reason for the revenue deviation lies in significantly lower non-recurring revenues, particularly in the A...
CompuGroup Medical SE & Co. KGaA
About the publication
01 July 2024 11:31AM
CGM receives C5 attestation according to BSI Criteria
DE000A288904
CGM receives C5 attestation according to BSI Criteria   Koblenz - CompuGroup Medical (CGM) has received C5 attestation (Type 1) for cloud services in Germany in accordance with the criteria of the German Federal Office for Information Security (BSI). Cloud products of CGM have been attested compliance with C5 criteria retroactively as of May 31, 2...
CompuGroup Medical SE & Co. KGaA
About the publication
25 June 2024 08:46PM
CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok
DE000A288904
CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok Fast growing, fully web-based ambulatory information system with added value for doctors due to great user experience Fast tracking the evolving customer needs regarding interoperability and data sharing Foundation for further expansion in...
CompuGroup Medical SE & Co. KGaA
About the publication
25 June 2024 08:46PM
CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok
DE000A288904
CompuGroup Medical strengthens market position in Northern Europe with the acquisition of Norwegian Pridok Fast growing, fully web-based ambulatory information system with added value for doctors due to great user experience Fast tracking the evolving customer needs regarding interoperability and data sharing Foundation for further expansion in...
CompuGroup Medical SE & Co. KGaA
About the publication
25 June 2024 08:41PM
CompuGroup Medical acquires Pridok AS
DE000A288904
Today, Profdoc AS, a 100% subsidiary of CompuGroup Medical SE & Co. KGaA, has entered into an agreement with the shareholders of Pridok AS to acquire 100% of the shares in Pridok AS. Pridok AS with its corporate seat in Tønsberg, Norway, offers a web-based digital patient journal system for the healthcare sector. In the financial year 2023, it...
CompuGroup Medical SE & Co. KGaA
About the publication
18 June 2024 11:34AM
CompuGroup Medical acquires AmbulApps
DE000A288904
CompuGroup Medical acquires AmbulApps   Koblenz - CompuGroup Medical acquires AmbulApps GmbH, a specialist in digital anamnesis tools. Founded in Neuss in 2015, the company organizes, digitizes and structures the collection of data from and about patients. CompuGroup Medical will integrate AmbulApps' applications into its portfolio of solutions an...
CompuGroup Medical SE & Co. KGaA
About the publication
22 May 2024 01:43PM
Shareholders approve dividend doubling to EUR 1.00
DE000A288904
CompuGroup Medical Annual General Meeting: Shareholders approve dividend doubling to EUR 1.00 Acts of the governing boards formally approved Dividend proposal of EUR 1.00 confirmed High approval rates for capital measures Focus on data-based solutions and artificial intelligence   Koblenz - The shareholders of CompuGroup Medical SE & Co....
CompuGroup Medical SE & Co. KGaA
About the publication
08 May 2024 07:07AM
CompuGroup Medical with solid first quarter against strong prior year
DE000A288904
CompuGroup Medical with solid first quarter against strong prior year Revenues down by 2%, organic growth of 3% adjusted for TI one-offs Recurring revenue share increases to 75% Advancing digitization in German and French healthcare Continuing revenue conversion of hospital order backlog Leverage reduced to 2.6x  Koblenz - At CompuGroup Medic...
CompuGroup Medical SE & Co. KGaA
About the publication
08 May 2024 07:07AM
CompuGroup Medical with solid first quarter against strong prior year
DE000A288904
CompuGroup Medical with solid first quarter against strong prior year Revenues down by 2%, organic growth of 3% adjusted for TI one-offs Recurring revenue share increases to 75% Advancing digitization in German and French healthcare Continuing revenue conversion of hospital order backlog Leverage reduced to 2.6x  Koblenz - At CompuGroup Medic...
CompuGroup Medical SE & Co. KGaA
About the publication
29 April 2024 02:49PM
CompuGroup Medical successfully completes share buyback program
DE000A288904
CompuGroup Medical successfully completes share buyback program Target reached before expiration date Company acquires 500,000 shares Volume of EUR 14.6 million Koblenz - CompuGroup Medical SE & Co. KGaA (CGM) has ended its share buyback program successfully on April 26 shortly before the expiration date. The target of a maximum of 500,000...
CompuGroup Medical SE & Co. KGaA
About the publication
29 April 2024 02:49PM
CompuGroup Medical successfully completes share buyback program
DE000A288904
CompuGroup Medical successfully completes share buyback program Target reached before expiration date Company acquires 500,000 shares Volume of EUR 14.6 million Koblenz - CompuGroup Medical SE & Co. KGaA (CGM) has ended its share buyback program successfully on April 26 shortly before the expiration date. The target of a maximum of 500,000...
CompuGroup Medical SE & Co. KGaA
About the publication
10 April 2024 03:26PM
CGM proposes dividend of EUR 1.00 to be passed at virtual AGM in May
DE000A288904
CGM proposes dividend of EUR 1.00 to be passed at virtual AGM in May Virtual Annual General Meeting on May 22, 2024 Agenda for the AGM published Dividend doubled to EUR 1.00   Koblenz - CompuGroup Medical SE & Co. KGaA (CGM) will hold its Annual General Meeting on May 22 again virtually this year. The virtual AGM format will enable a direc...
CompuGroup Medical SE & Co. KGaA
About the publication
25 March 2024 07:15PM
CompuGroup Medical SE & Co. KGaA adopts resolution on share buy-back program for up to 500,000 shares
DE000A288904
The general partner of CompuGroup Medical SE & Co. KGaA (the “Company”) (ISIN: DE000A288904 | WKN: A28890), utilizing the authorization granted by its annual general meeting of May 19, 2021 pursuant to section 71(1) no. 8 of the German Stock Corporation Act (Aktiengesetz), resolved today to buy back a maximum number of up to 500,000 shares of t...
CompuGroup Medical SE & Co. KGaA
About the publication
25 March 2024 12:32PM
CompuGroup Medical US announces CEO transition
DE000A288904
CompuGroup Medical US announces CEO transition   Austin, TX – Underlining the commitment to its second largest market worldwide by revenue, CompuGroup Medical announces the appointment of Benedikt Brueckle as its new Chief Executive Officer for the US, effective January 1, 2025. Benedikt Brueckle is a respected and experienced leader in the healt...
CompuGroup Medical SE & Co. KGaA
About the publication
25 March 2024 12:32PM
CompuGroup Medical US announces CEO transition
DE000A288904
CompuGroup Medical US announces CEO transition   Austin, TX – Underlining the commitment to its second largest market worldwide by revenue, CompuGroup Medical announces the appointment of Benedikt Brueckle as its new Chief Executive Officer for the US, effective January 1, 2025. Benedikt Brueckle is a respected and experienced leader in the healt...
CompuGroup Medical SE & Co. KGaA
About the publication
20 February 2024 08:37PM
CGM plans to double its dividend
DE000A288904
CGM plans to double its dividend Koblenz. The general partner of CompuGroup Medical SE & Co. KGaA (CGM) intends to sustainably increase the dividend to a higher level, and will therefore propose a dividend of EUR 1.00 per share to the Annual General Meeting for the financial year 2023. Based on the 52.2 million shares currently entitled to a d...
CompuGroup Medical SE & Co. KGaA
About the publication
20 February 2024 08:35PM
General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase
DE000A288904
General partner of CompuGroup Medical SE & Co. KGaA plans dividend increase Against the background of the stable financial and earnings position the general partner of CompuGroup Medical SE & Co. KGaA (CGM) intends to sustainably increase the dividend payment to a higher level. Therefore, the general partner plans to propose to the Annual ...
CompuGroup Medical SE & Co. KGaA
About the publication
07 February 2024 07:03AM
CGM drives digitization in the healthcare sector and significantly increases revenues and operating profit margin
DE000A288904
CGM drives digitization in the healthcare sector and significantly increases revenues and operating profit margin Group revenues increase by 5% to EUR 1.19 billion in 2023 Organic growth of 4.3% (5.3% ex TI) compared to strong previous year Share of recurring revenue climbs to new high of 69% Adjusted EBITDA increases by 13% to EUR 265 millio...
CompuGroup Medical SE & Co. KGaA
About the publication
30 January 2024 09:40AM
CGM with positive interim assessment
DE000A288904
E-prescriptions new standard in Germany: CGM with positive interim assessment   Koblenz. In the first four weeks of this year, around 12 million e-prescriptions were issued in the German ambulatory information systems of CompuGroup Medical (CGM) alone. This means more e-prescriptions than redeemed overall in Germany between July 2021 and early De...
CompuGroup Medical SE & Co. KGaA
About the publication
14 December 2023 10:09AM
CGM registers significant increase in issued e-prescriptions
DE000A288904
CGM registers significant increase in issued e-prescriptions Koblenz. The digitization of the German healthcare system is gaining more momentum: Last week, 715,000 e-prescriptions were issued in the Ambulatory Information Systems of CompuGroup Medical (CGM) alone. This represents an increase of 45 percent compared to the previous week. In the two-...
CompuGroup Medical SE & Co. KGaA
About the publication
09 November 2023 07:07AM
CGM continues to drive digitization in healthcare and reports 10 % revenue growth in first nine months
DE000A288904
CGM continues to drive digitization in healthcare and reports 10 % revenue growth in first nine months   CGM supports ramp-up in usage of digital modules to improve the patient journey Increasing momentum in projects relating to Hospital Future Act Growing relevance of data & AI based solutions 8 % organic growth with 68 % recurring revenu...
CompuGroup Medical SE & Co. KGaA
About the publication
16 October 2023 10:47AM
CompuGroup Medical successfully places Schuldschein of EUR 300 million
DE000A288904
CompuGroup Medical successfully places Schuldschein of EUR 300 million   CompuGroup Medical SE & Co. KGaA (CGM), one of the world's leading e-health providers, has successfully placed Schuldschein tranches with a total volume of EUR 300 million. The transaction was the Koblenz-based company's debut in the international debt capital market, in...
CompuGroup Medical SE & Co. KGaA
About the publication
05 October 2023 08:25AM
CompuGroup Medical bundles data-based solutions with ambulatory information systems and appoints Daniela Hommel as CFO
DE000A288904
CompuGroup Medical bundles data-based solutions with ambulatory information systems and appoints Daniela Hommel as CFO   CGM integrates business activities of the CHS segment into the AIS segment Managing Director Consumer Health Management Information Systems Dr. Eckart Pech leaves CGM at his own request at the end of March 2024 after successf...
CompuGroup Medical SE & Co. KGaA
About the publication
07 September 2023 09:30AM
CGM reports on growth initiatives and proprietary AI tool at Capital Markets Day
DE000A288904
CGM reports on growth initiatives and proprietary AI tool at Capital Markets Day   Launch of the company's AI tool ChatCGM CGM sees great potential of AI in the healthcare sector Innovation offensive 2021/2022 successful: Organic growth sustainably at 5 percent and more Digitization in medical practices, hospitals and pharmacies remains growth...
CompuGroup Medical SE & Co. KGaA
About the publication
10 August 2023 07:24AM
CompuGroup Medical launches AI initiative improving healthcare IT products and solutions
DE000A288904
CompuGroup Medical launches AI initiative improving healthcare IT products and solutions   CGM AI Initiative launched in the second quarter More face-to-face time with patients for doctors and healthcare practitioners Strengthening R&D and business operations with high data protection standards Continued investments into new technologies f...
CompuGroup Medical SE & Co. KGaA
About the publication
10 August 2023 07:13AM
CompuGroup Medical delivers excellent profitable growth in second quarter
DE000A288904
CompuGroup Medical delivers excellent profitable growth in second quarter   15 % growth in Q2 2023 with revenues of EUR 304 million Organic growth of 13 % driven by connectivity and hospital business Recurring revenue share of 66 % reflects strength of business model Adj. EBITDA up by 36 % at EUR 73 million Strong free cash flow of EUR 83 mi...
CompuGroup Medical SE & Co. KGaA
About the publication
17 May 2023 01:10PM
CGM appoints Michael Rauch as CEO and reports on successful financial year and board changes at virtual AGM
DE000A288904
CGM appoints Michael Rauch as CEO and reports on successful financial year and board changes at virtual AGM   Administrative Board assigns Michael Rauch as CEO effective immediately Annual General Meeting decides on EUR 0.50 dividend Reinhard Lyhs confirmed as new Supervisory Board Member Dr. Ulrich Thomé takes over as new Managing Director A...
CompuGroup Medical SE & Co. KGaA
About the publication
17 May 2023 01:10PM
CGM appoints Michael Rauch as CEO and reports on successful financial year and board changes at virtual AGM
DE000A288904
CGM appoints Michael Rauch as CEO and reports on successful financial year and board changes at virtual AGM   Administrative Board assigns Michael Rauch as CEO effective immediately Annual General Meeting decides on EUR 0.50 dividend Reinhard Lyhs confirmed as new Supervisory Board Member Dr. Ulrich Thomé takes over as new Managing Director A...
CompuGroup Medical SE & Co. KGaA
About the publication
17 May 2023 08:31AM
CompuGroup Medical Administrative Board appoints Michael Rauch as CEO
DE000A288904
At its meeting prior to today’s Annual General Meeting, the Administrative Board of CompuGroup Medical Management SE, general partner of CompuGroup Medical SE & Co. KGaA (CGM), one of the world’s leading e-health providers, appointed Michael Rauch, the current Speaker for the Managing Directors and longtime Chief Financial Officer (CFO), as Chi...
CompuGroup Medical SE & Co. KGaA
About the publication
17 May 2023 08:31AM
CompuGroup Medical Administrative Board appoints Michael Rauch as CEO
DE000A288904
At its meeting prior to today’s Annual General Meeting, the Administrative Board of CompuGroup Medical Management SE, general partner of CompuGroup Medical SE & Co. KGaA (CGM), one of the world’s leading e-health providers, appointed Michael Rauch, the current Speaker for the Managing Directors and longtime Chief Financial Officer (CFO), as Chi...
CompuGroup Medical SE & Co. KGaA
About the publication
10 May 2023 07:24AM
CompuGroup Medical with 16% revenue growth in the first quarter
DE000A288904
CompuGroup Medical with 16% revenue growth in the first quarter  11% organic growth driven by digitization and connectivity in healthcare Recurring revenue share of 68% reflects strength of business model 16% adjusted EBITDA growth despite additional project investments Revenue target related to the Hospital Future Act raised again Majority ...
CompuGroup Medical SE & Co. KGaA
About the publication
10 May 2023 07:24AM
CompuGroup Medical with 16% revenue growth in the first quarter
DE000A288904
CompuGroup Medical with 16% revenue growth in the first quarter  11% organic growth driven by digitization and connectivity in healthcare Recurring revenue share of 68% reflects strength of business model 16% adjusted EBITDA growth despite additional project investments Revenue target related to the Hospital Future Act raised again Majority ...
CompuGroup Medical SE & Co. KGaA
About the publication
24 April 2023 08:27AM
CompuGroup Medical acquires majority stake in patient portal provider m.Doc
DE000A288904
Koblenz. CompuGroup Medical SE & Co. KGaA has acquired 51% of m.Doc GmbH. m.Doc develops patient portals and digital applications for hospitals, rehabilitation and care facilities. Founded in 2016, the company has offices in Cologne and Lisbon with around 110 employees. CompuGroup Medical will further develop m.Doc's patient portal and integrat...
CompuGroup Medical SE & Co. KGaA
About the publication
24 April 2023 08:27AM
CompuGroup Medical acquires majority stake in patient portal provider m.Doc
DE000A288904
Koblenz. CompuGroup Medical SE & Co. KGaA has acquired 51% of m.Doc GmbH. m.Doc develops patient portals and digital applications for hospitals, rehabilitation and care facilities. Founded in 2016, the company has offices in Cologne and Lisbon with around 110 employees. CompuGroup Medical will further develop m.Doc's patient portal and integrat...
CompuGroup Medical SE & Co. KGaA
About the publication
03 April 2023 04:24PM
CGM proposes dividend on prior year’s level to be passed at virtual AGM in May
DE000A288904
CGM proposes dividend on prior year’s level to be passed at virtual AGM in May Virtual Annual General Meeting on May 17, 2023 Agenda for the AGM published Dividend on prior year’s level at EUR 0.50 Koblenz. Due to the positive experiences with the virtual format and to make it easier for international investors to participate without additional ...
CompuGroup Medical SE & Co. KGaA
About the publication
03 April 2023 04:24PM
CGM proposes dividend on prior year’s level to be passed at virtual AGM in May
DE000A288904
CGM proposes dividend on prior year’s level to be passed at virtual AGM in May Virtual Annual General Meeting on May 17, 2023 Agenda for the AGM published Dividend on prior year’s level at EUR 0.50 Koblenz. Due to the positive experiences with the virtual format and to make it easier for international investors to participate without additional ...
CompuGroup Medical SE & Co. KGaA
About the publication
09 February 2023 07:32AM
CompuGroup Medical SE & Co. KGaA: CGM in 2022 with double-digit revenue growth – strong 2023 guidance underlines mid-term ambitions
DE000A288904
CGM in 2022 with double-digit revenue growth – strong 2023 guidance underlines mid-term ambitions   10 % growth in 2022 with revenues of EUR 1,130 million Organic growth of 4.1 % against strong prior year, like-for-like organic growth of 6.3 % Recurring revenue increase of 10 % reflects resilience of business model Strong execution in ambulat...
CompuGroup Medical SE & Co. KGaA
About the publication
More CompuGroup Medical SE & Co. KGaA related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 25 22nd March 2024 Hommel, Daniela DD
Short Seller (DE) 2 19th December 2024 Qube Research & Technologies Limited SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN